文献速递肝病

过去三十年间欧洲原发性胆汁性胆管炎肝移植的趋势

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.
PubMed 文献 · Aliment Pharmacol Ther · 2018-12-18

研究纳入1986至2015年欧洲肝移植登记处112874例成人肝移植患者,其中6029例(5.3%)为原发性胆汁性胆管炎。原发性胆汁性胆管炎肝移植比例从1986年20%降至2015年4%(P<0.001),年移植例数在初期增长后稳定在约200例。

要点

  • 原发性胆汁性胆管炎肝移植比例从1986年20%降至2015年4%(P<0.001)。
  • 年肝移植例数在首个十年增长后稳定在约200例。
  • 肝移植年龄从第一十年54岁(IQR 47-59)增至第三十年56岁(IQR 48-62),男性比例从11%升至15%(均P<0.001)。

核心结论

  • 原发性胆汁性胆管炎作为肝移植适应证的比例下降,但尽管使用熊去氧胆酸治疗且疾病认知提高,年绝对肝移植例数已稳定。

研究设计与样本

  • 基于欧洲肝移植登记处报告中心的1986至2015年肝移植患者,排除联合器官移植和年龄<18岁者,共纳入112874例,其中6029例(5.3%)为原发性胆汁性胆管炎。
  • 趋势采用线性回归模型评估。

主要发现

  • 原发性胆汁性胆管炎肝移植比例从1986年20%降至2015年4%(P<0.001)。
  • 年肝移植例数在首个十年增长后稳定在约200例。
  • 原发性胆汁性胆管炎是唯一在所有十年间均呈持续比例下降的适应证。
  • 肝移植年龄从第一十年54岁(IQR 47-59)增至第三十年56岁(IQR 48-62)(P<0.001)。
  • 男性比例从第一十年11%增至第三十年15%(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The importance of primary biliary cholangitis as an indication for liver transplantation has probably been influenced by the introduction of therapies, and changes in selection criteria and disease epidemiology. AIMS: To assess the time trends in liver transplantation for primary biliary cholangitis and to evaluate the characteristics of the patient population during the past three decades. METHODS: Patients undergoing liver transplantation from 1986 to 2015 in centres reporting to the European Liver Transplantation Registry were included. We excluded combined organ transplantations and patients <18 years. Trends were assessed using linear regression models. RESULTS: We included 112 874 patients, of whom 6029 (5.3%) had primary biliary cholangitis. After an initial increase in the first decade, the annual number of liver transplantation for primary biliary cholangitis remained stable at around 200. The proportion of liver transplantations for primary biliary cholangitis decreased from 20% in 1986 to 4% in 2015 (P < 0.001). Primary biliary cholangitis was the only indication showing a consistent proportional decrease throughout all decades. From the first to the third decade, the age at liver transplantation increased from 54 (IQR 47-59) to 56 years (IQR 48-62) and the proportion of males increased from 11% to 15% (both P < 0.001). CONCLUSIONS: We have found a proportional decrease in primary biliary cholangitis as indication for liver transplantation. However, despite treatment with ursodeoxycholic acid and improved disease awareness, the absolute annual number of liver transplantations has stabilised.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Harms MH, Janssen QP, Adam R, et al. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Aliment Pharmacol Ther. 2018. PMID: 30561112. doi:10.1111/apt.15060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。